Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: A cohort study

Clinical and Experimental Allergy

Volumn 44, Issue 2, 2014, Pages 261-269

  Mulder, B ^a   Schuiling Veninga, C C M ^a   Bos, H J ^a   De Vries, T W ^b   Jick, S S ^c,d   Hak, E ^a,e  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d Boston Collaborative Drug Surveillance Program   (United States)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Acid suppressive drugs; Asthma; Atopic dermatitis; Child; Epidemiology; Pregnancy; Rhinitis

Indexed keywords

CORTICOSTEROID; HISTAMINE H2 RECEPTOR ANTAGONIST; PIMECROLIMUS; PROTON PUMP INHIBITOR; STEROID; TACROLIMUS;

ADULT; AGE DISTRIBUTION; ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; COHORT ANALYSIS; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTCOME ASSESSMENT; PRENATAL EXPOSURE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PROGENY; RISK; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ACID-SUPPRESSIVE DRUGS; ASTHMA; ATOPIC DERMATITIS; CHILD; EPIDEMIOLOGY; PREGNANCY; RHINITIS;

ADOLESCENT; ADULT; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84892714313     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12227     Document Type: Article

References (36)

1. ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. Lancet 1998; 351:1225-32.
2. Shaheen SO, Newson RB, Henderson AJ et al. Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood. Clin Exp Allergy 2005; 35:18-25.
3. Jedrychowski W, Galas A, Whyatt R, Perera F. The prenatal use of antibiotics and the development of allergic disease in one year old infants. A preliminary study. Int J Occup Med Environ Health 2006; 19:70-6.
4. McKeever TM, Lewis SA, Smith C, Hubbard R. The importance of prenatal exposures on the development of allergic disease. A birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med 2002; 15:827-32.
5. Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med 2010; 363:2114-23.
6. Dehlink E, Yen E, Leichtner AM, Hait EJ, Fiebiger E. First evidence of a possible association between gastric acid suppression during pregnancy and toddler asthma: a population-based register study. Clin Exp Allergy 2009; 39:246-53.
7. Andersen ABT, Erichsen R, Farkas DK, Mehnert F, Ehrenstein V, Sorensen HT. Prenatal exposure to acid-suppressive drugs and the risk of toddler asthma: a population-based Danish cohort study. Aliment Pharmacol Ther 2012; 35:1190-8.
8. Kallen B, Finnstrom O, Nygren K-G, Otterblad Olausson P. Maternal drug use during pregnancy and asthma risk among children. Pediatr Allergy Immunol 2013; 24:28-32.
9. Mulder B, Schuiling-Veninga CCM, Bos JH, De Vries TW, Hak E. Acid-supressive drug use in pregnancy and the toddler's asthma risk: a crossover, case-control study. J Allergy Clin Immunol 2013; 132:1438-1440.e1.
10. Hak E, Mulder B, Schuiling-Veninga CCM, Bos JH, De Vries TW, Jick SS. Use of acid-suppressive drugs in pregnancy and the risk of childhood asthma: bidirectional case-crossover study using the General Practice Research Database. Drug Saf 2013; 36:1097-104.
11. Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010; 2:99-106.
12. Visser ST, Schuiling-Veninga CC, Bos JH, de Jong-van den Berg LT, Postma MJ. The population-based prescription database IADB.nl: its development, usefulness in outcome research and challenges. Expert Rev Pharmacoecon Outcomes Res 2013; 13:285-92.
13. Leufkens B, Urquart J. Automated Pharmacy Record Linkage in the Netherlands. In: Strom BL, ed. Pharmacoepidemiology. Chisester: John Wiley & Sons, 2005:311-22.
14. Schirm E, Tobi H, de Jong-van den Berg LT. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn toddlers. J Clin Epidemiol 2004; 57:737-41.
15. Smith GD. Assessing intrauterine influences on offspring health outcomes: can epidemiological studies yield robust findings? Basic Clin Pharmacol Toxicol 2008; 102:245-56.
16. NHG (Dutch General Practitioner Guidelines). Available at: https://www.nhg.org/standaarden/volledig/nhg-standaard-astma-bij-kinderen. (Last accessed 8th August 2013).
17. NHG (Dutch General Practitioner Guidelines). Available at: https://www.nhg.org/standaarden/volledig/nhg-standaard-constitutioneel-eczeem. (Last accessed 8th August 2013).
18. NHG (Dutch General Practitioner Guidelines). Available at: https://www.nhg.org/standaarden/samenvatting/allergische-en-niet-allergische-rhinitis. (Last accessed 8th August 2013).
19. de Vries TW. Improving care in paediatric asthma: patients, prescriptions, pharmacovigilance, pathogens, and particles (doctoral dissertation). Groningen: University of Groningen, 2008.
20. Verboom P, Hakkaart-Van Roijen L, Sturkenboom M, De Zeeuw R, Menke H, Rutten F. The cost of atopic dermatitis in the Netherlands: an international comparison. British J Dermatol 2002; 147:716-24.
21. Moth G, Vedsted P, Schiotz PO. Identification of asthmatic children using prescription data and diagnosis. Eur J Clin Pharmacol 2007; 63:605-11.
22. Pont LG, van der Werf GT, Denig P, Haaijer-Ruskamp FM. Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data. Eur J Clin Pharmacol 2002; 57:819-25.
23. De Bot CMA, Moed H, Schellevis FG, De Groot H, Van Wijk RG, Van Der Wouden JC. Allergic rhinitis in children: incidence and treatment in Dutch general practice in 1987 and 2001. Pediat Allergy Immunol 2008; 20:571-7.
24. McKeever TM, Lewis SA, Smith C et al. Siblings, multiple births, and the incidence of allergic disease: a birth cohort study using the West Midlands general practice research database. Thorax 2001; 56:758-62.
25. Martinez FD, Wright AL, Holberg CJ, Morgan WJ, Taussig LM. Maternal age as a risk factor for wheezing lower respiratory illnesses in the first year of life. Am J Epidemiol 1992; 136:1258-68.
26. Sears MR, Burrows B, Flannery EM, Herbison GP, Holdaway MD. Atopy in childhood. I. Gender and allergen related risks for development of hay fever and asthma. Clin Exp Allergy 1993; 23:941-8.
27. Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenteral Nutr 2007; 45:421-7.
28. R Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07. Available at: http://www.R-project.org/.
29. Bakker MK, de Walle HE, Dequito A, van den Berg PB, de Jong-van den Berg LT. Selection of controls in case-control studies on maternal medication use and risk of birth defects. Birth Defects Res A Clin Mol Teratol 2007; 79:652-6.
30. Verstappen GMPJ, Smolders EJ, Munster JM, Aarnoudse JG, Hak E. Prevalence and predictors of over-the-counter medication use among pregnant women: a cross-sectional study in the Netherlands. BMC Public Health 2013; 13:185.
31. Scholl I, Untersmayr E, Bakos N et al. Antiulcer drugs promote oral sensitization and hypersensitivity to hazelnut allergens in BALB/c mice and humans. Am J Clin Nutr 2005; 81:154-60.
32. Untersmayr E, Scholl I, Swoboda I et al. Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice. J Allergy ClinImmunol 2003; 112:616-23.
33. Pali-Scholl I, Herzog R, Wallmann J et al. Antacids and dietary supplements with an influence on the gastric pH increase the risk for food sensitization. Clin Exp Allergy 2010; 40:1091-8.
34. Scholl I, Ackermann U, Ozdemir C et al. Anti-ulcer treatment during pregnancy induces food allergy in mouse mothers and a Th2-bias in their offspring. FASEB J 2007; 21:1264-70.
35. Szepfalusi Z, Loibichler C, Pichler J, Reisenberger K, Ebner C, Urbanek R. Direct evidence for transplacental allergen transfer. Pediatr Res 2000; 48:404-7.
36. Kopp MV, Zehle C, Pichler J et al. Allergen-specific T cell reactivity in cord blood: the influence of maternal cytokine production. Clin Exp Allergy 2001; 31:1536-43.